Discovery and optimization of a novel series of potent mutant B-Raf V600E selective kinase inhibitors
B-Raf represents an attractive target for anticancer therapy and the development of small molecule B-Raf inhibitors has delivered new therapies for metastatic melanoma patients. We have discovered a novel class of small molecules that inhibit mutant B-Raf
The invention relates to chemical compounds of the formula (I): or pharmaceutically or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of trea
-
Page/Page column 34
(2008/12/06)
More Articles about upstream products of 1032573-76-4